ARTICLE SUMMARY:
Beyond the hype, we know a lot more about controlling stem cell behavior and advanced biomaterials that could lead to new tools for soft tissue regeneration and osteoarthritis, says Washington University’s Farshid Guilak. Part two of a three-part series.
Regenerative medicine, perhaps more than any other scientific field, is currently at the intersection of developments in biopharma, medical devices and engineering, and its role in the medical device world is hard to stratify.
